Loading…
Loading…
EQUITY / OTC · PSGM
US BioTec, Inc.
Following is saved. Automatic company research is not available for this coverage; explore the evidence with Research.
No accepted understanding yet. Follow this company to establish research where evidence supports it.
Open research workspace →04/01/2026 – 06/30/2026 · USD · Units
Reported figures establish facts for this period; they do not by themselves establish a profitability trend.
Open report ↗0.5513 USD · 2.0926%
Observed: Oct 6, 2026, 4:21 PM · TickerLayer indicative price; may be delayed
Powered by TickerLayer
10/05/2026 · 0.54 USD · Volume 245,749
63 actual observations · Latest bar: 2026-10-05 · Market data is indicative; provider terms apply.
8 available financial reports
Research reports →SEC FINANCIAL REPORTS
04/01/2026 – 06/30/2026 · Units
| Metric | 2026 / Quarter 2 | 2025 / Quarter 2 | Change |
|---|---|---|---|
| Operating profit | -16,430,235 USD | -1,254,345 USD | — |
| Net income | -20,788,574 USD | -1,528,601 USD | — |
| Cash and cash equivalents | 2,982,232 USD | — | — |
| Total liabilities | 20,086,310 USD | — | — |
| Total equity | 46,400,861 USD | -4,792,199 USD | — |
Changes are calculated only for matching period length, consolidation, currency, and scale. Percentages are not shown for zero or negative baselines.
Each column uses its report's scale. Check column headers before comparing different consolidation scopes and scales.
| Financial metric | 2026 / Quarter 204/01/2026 – 06/30/2026ConsolidatedUnits · USD | 2026 / Quarter 201/01/2026 – 06/30/2026ConsolidatedUnits · USD | 2026 / Quarter 201/01/2026 – 03/31/2026ConsolidatedUnits · USD | 2026 / Quarter 212/31/2025 – 12/31/2025ConsolidatedUnits · USD | 2026 / Year end10/01/2025 – 12/31/2025ConsolidatedUnits · USD | 2025 / Year end10/01/2024 – 09/30/2025ConsolidatedUnits · USD | 2025 / Quarter 204/01/2025 – 06/30/2025ConsolidatedUnits · USD | 2025 / Quarter 201/01/2025 – 06/30/2025ConsolidatedUnits · USD |
|---|---|---|---|---|---|---|---|---|
| Cash and cash equivalentsBalance sheet | 2,982,232 USD | — | — | 4,092,308 USD | 4,100,000 USD | — | — | — |
| Net incomeIncome statement | -20,788,574 USD | -46,343,343 USD | -25,554,769 USD | — | -27,455,848 USD | -22,123,349 USD | -1,528,601 USD | -5,107,637 USD |
| Operating profitIncome statement | -16,430,235 USD | -28,097,495 USD | — | — | -17,127,721 USD | -18,046,593 USD | -1,254,345 USD | -3,461,867 USD |
| Total assetsBalance sheet | 66,487,171 USD | — | — | 93,670,930 USD | 93,670,930 USD | 125,079,228 USD | — | — |
| Total equityBalance sheet | 46,400,861 USD | — | 59,902,561 USD | 81,531,775 USD | 81,531,775 USD | 97,119,171 USD | -4,792,199 USD | — |
| Total liabilitiesBalance sheet | 20,086,310 USD | — | — | 12,139,155 USD | 12,139,155 USD | 27,960,057 USD | — | — |
| Financing cash flowCash flow statement | — | 15,000,330 USD | — | — | -99,497 USD | 13,306,952 USD | — | 1,730,623 USD |
| Investing cash flowCash flow statement | — | -225,000 USD | — | — | 0 USD | 0 USD | — | 0 USD |
| Operating cash flowCash flow statement | — | -15,225,406 USD | — | — | -4,630,194 USD | -7,595,708 USD | — | -2,590,449 USD |
| Capital expendituresCash flow statement | — | — | — | — | 0 USD | 0 USD | — | — |
| Report source | Open report ↗ Published: 08/07/2026 | Open report ↗ Published: 08/07/2026 | Open report ↗ Published: 08/07/2026 | Open report ↗ Published: 08/07/2026 | Open report ↗ Published: 03/25/2026 | Open report ↗ Published: 03/25/2026 | Open report ↗ Published: 08/07/2026 | Open report ↗ Published: 08/07/2026 |
The latest available source version is shown for each period. Previous versions and correction relationships are not shown in this view.